F710 in District of Columbia. Pick another state for the same tag.
Against expectation — 2024
District of Columbia cites F710 more often than its own record predicts
Versus expected share6.28×
6.28 times the share F710 takes of citations nationally.
Share of District of Columbia citations0.51%
Of every deficiency written in District of Columbia in 2024, this is the portion that was F710.
District of Columbia0.51%
National0.08%
Share of all citations that were F710.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What District of Columbia surveyors wrote
F710 findings written in District of Columbia, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedMay 23, 2024
Based on record reviews and staff interviews, for one (1) of 94 sampled residents, the nurse practitioner failed to timely address a resident's known subtherapeutic Valporic Acid (anitconvulsant medication) level. Resident #120.
The findings included:
According to the National Institute of Health (NIH), Valproic Acid (VPA) is a medication used to treat neurological and psychiatric disorders. The therapeutic uses of VPA include epilepsy treatment across different seizure types, bipolar disorder management, and migraine. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction